Conversely, type I LCNECs and the majority of the SCLC samples (class III and IV) showed higher levels of neuroendocrine genes, as well as of ASCL1 and DLL3, and downregulation of NOTCH pathway genes (Fig. 3d, Supplementary Fig. 12f). This evidence concerns the gene DLL3 and small cell lung carcinoma.